Lead asset is a TEAD1 inhibitor IK-930 targeting the HIPPO pathway. It works through disruption of the link between transcriptional enhancer activator domain (TEAD') and its co-activator ...
As healthcare becomes more entrenched in the digital revolution, the need for an approved set of protocols for care delivery — clinical pathways — is becoming increasingly critical. Clinical pathways, ...
CHICAGO--(BUSINESS WIRE)--Syntellis Performance Solutions, the leading provider of enterprise performance management software, data and intelligence solutions, today announced the launch of Focus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results